INMED PHARMACEUTICALS INC. Adjustments to Additional Paid in Capital, Warrant Issued
INMED PHARMACEUTICALS INC. (INM) reported Adjustments to Additional Paid in Capital, Warrant Issued of $5.02 million for the 12-month period ending 2025-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $739.92K.
- INMED PHARMACEUTICALS INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $1.31M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2025-06-30 | $5.02M S-4/A · filed 2026-09-09 | |
| 2022-06-30 | $1.31M 10-K · filed 2023-09-29 | |
| 2021-09-30 | $739.92K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |